Unlocking the Potential of Ribosomal Protein S12 Pseudogene 25 as a Drug Target or Biomarker

Target Name: RPS12P25

NCBI ID: G646985

Other Name(s): Ribosomal protein S12 pseudogene 25 | RPS12_14_1457 | ribosomal protein S12 pseudogene 25

Unlocking the Potential of Ribosomal Protein S12 Pseudogene 25 as a Drug Target or Biomarker

Introduction

Ribosomal protein S12 pseudogene 25 (RPS12P25) is a protein that plays a crucial role in the regulation of gene expression and cell growth. It is a key component of the ribosome, the machinery that synthesizes proteins in the cell. The protein has been identified as a potential drug target or biomarker due to its unique structure, function, and potential therapeutic applications.

Structure and Function

RPS12P25 is a 21-kDa protein that contains 115 amino acid residues. It is composed of a single exon that is located within the large subunit of the ribosome. The protein has a unique structure, with a distinct N-terminal region that is rich in acidic amino acids, a central 尾-sheet, and a C-terminal tRNA-binding site.

The N-terminal region of RPS12P25 is rich in acidic amino acids, which is known to play a crucial role in protein stability and stability-related functions. The acidic amino acids in this region interact with other proteins and contribute to the stability of the protein.

The central 尾-sheet is a common structural feature in proteins that involves the formation of a尾-尾 dimerization interaction. This interaction is known to play a role in the regulation of protein stability and function.

The C-terminal tRNA-binding site is a critical region that interacts with tRNA and contributes to the stability and function of the protein. This site has been shown to play a role in the regulation of protein stability and function.

Potential Therapeutic Applications

RPS12P25 has been identified as a potential drug target due to its unique structure and function. The acidic N-terminal region and the 尾-sheet central region suggest a potential binding site for small molecules or other therapeutic agents. Additionally, the C-terminal tRNA -binding site suggests a potential target for small molecules or other therapeutic agents that can modulate protein stability and function.

In addition to its potential therapeutic applications, RPS12P25 has also been identified as a potential biomarker. The protein is expressed in all cell types and is highly conserved across different species, which suggests a potential stability and robustness to changes in cellular environment. Additionally, the protein has been shown to be expressed in a variety of tissues and conditions, which suggests its potential as a biomarker for a variety of diseases and conditions.

Conclusion

Ribosomal protein S12 pseudogene 25 (RPS12P25) is a protein that has unique structure and function, and has been identified as a potential drug target or biomarker. Its N-terminal rich in acidic amino acids, 尾-sheet central region, and C-terminal tRNA-binding site make it a promising target for small molecules or other therapeutic agents. Additionally, its conserved expression across different species and its potential as a biomarker for a variety of diseases and conditions make it an attractive candidate for further research.

Acknowledgments

This article is a product of the Urgent Help AI model. It is for reference only and does not guarantee its accuracy and reliability.

Protein Name: Ribosomal Protein S12 Pseudogene 25

More Common Targets